Oral liquid hydroxyurea promising for long-term use in babies with sickle cell anemia


HUSOFT extension study at St. Jude shows hydroxyurea is well tolerated in babies, works similarly as in older children, and may prevent sickle cell complications such as organ damage and stunted growth

Source: Eurekalert & others

Last reviewed: By John M. Grohol, Psy.D. on 21 Feb 2009
    Published on PsychCentral.com. All rights reserved.